Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 USD | +1.49% | +6.99% | -28.58% |
Sales 2024 * | 1.28B 106B | Sales 2025 * | 1.34B 111B | Capitalization | 337M 28.08B |
---|---|---|---|---|---|
Net income 2024 * | -115M -9.59B | Net income 2025 * | -104M -8.67B | EV / Sales 2024 * | 0.2 x |
Net cash position 2024 * | 82.5M 6.88B | Net cash position 2025 * | 71.7M 5.98B | EV / Sales 2025 * | 0.2 x |
P/E ratio 2024 * |
-3.08
x | P/E ratio 2025 * |
-3.43
x | Employees | 552 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.67% |
Latest transcript on Clover Health Investments, Corp.
1 day | +1.49% | ||
1 week | +6.99% | ||
Current month | -14.36% | ||
1 month | -12.90% | ||
3 months | -29.18% | ||
6 months | -28.41% | ||
Current year | -28.58% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Toy
FOU | Founder | 45 | 17/14/17 |
Vivek Garipalli
FOU | Founder | 46 | 17/14/17 |
Terrence Ronan
DFI | Director of Finance/CFO | 64 | 02/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lee Shapiro
BRD | Director/Board Member | 68 | 07/21/07 |
Vivek Garipalli
FOU | Founder | 46 | 17/14/17 |
Chelsea Clinton
BRD | Director/Board Member | 44 | 01/17/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 237 M€ | +2.89% | - | |
0.02% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.68 | +1.49% | 2,324,970 |
25/24/25 | 0.67 | +3.08% | 3,911,525 |
24/24/24 | 0.65 | +3.19% | 4,001,131 |
23/24/23 | 0.6299 | +1.24% | 3,503,688 |
22/24/22 | 0.6222 | -2.11% | 3,919,525 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.58% | 337M | |
-5.91% | 456B | |
+13.93% | 125B | |
+18.37% | 101B | |
-0.28% | 39.69B | |
-33.18% | 36.86B | |
-5.28% | 20.05B | |
-13.82% | 3.08B |
- Stock Market
- Equities
- CLOV Stock